MycoTact®

Accelerating Tuberculosis Detection

Tuberculosis (TB) remains one of the deadliest infectious diseases worldwide, with over 10 million new cases and 1.5 million deaths annually. The TB diagnostics market is valued at over $2.5 billion, with growing demand for rapid, accessible testing in both high- and low-resource settings.
New TB cases 0M Million per year (WHO)
Pexels Vlada Karpovich 5790807

Current TB diagnostic Challenges

  • Slow Turnaround: Growth culture methods take weeks, delaying urgent care and enabling transmission
  • High-cost, Complex Diagnostics: NAAT-based tests require complex readers
  • Shortage of Skilled Staff: Sputum microscopy requires specialized equipment and trained personnel
  • Inability to detect viable Infection: NAAT tests can’t distinguish between live and dead bacilli
  • Drug Resistance: MDR-TB and XDR-TB are on the rise, increasing the need for faster and reliable diagnostics

Without accessible, rapid diagnostic tools, TB continues to spread unchecked, with severe global health and economic consequences.

Our Solution

2025 03 26 DetactDiagnostics CasperMaas CMA9046
MycoTact©

Accelerating TB Detection

MycoTact® is a fast, user-friendly test that directly detects viable Mycobacterium tuberculosis within minutes. Unlike current tests, MycoTact® provides real-time, point-of-care TB testing

How MycoTact® works

2025 03 26 DetactDiagnostics CasperMaas CMA9088
Collect

No Sample Prep

Directly transfer sample to the VIPER® assay tube containing the MycoTact® assay
2025 03 26 DetactDiagnostics CasperMaas CMA9031
Read

Reader Agnostic

Place the VIPER® assay tube containing the sample, into the DeNIRO® mini Fluorometer (point-of-care) or plate reader (lab-based testing)
Roberto Sorin RS0 H PyByk Unsplash
Treat

Actionable Results

MycoTact® provides actionable data within minutes enabling health care professionals to start immediate targeted treatment

Benefits to healthcare providers

Supports Early Intervention

Enables prompt treatment to reduce transmission and complications

Fast Detection

Identifies TB infections in minutes, not days

Cost Effective

Reduces reliance on costly lab infrastructure and specialized technicians

Accessible Testing

Suitable for out-patient clinics, hospitals, and remote settings

Our Point-of-Care NIR Fluorometer

Screenshot 2025 04 02 At 15.03.06

Breakthrough Technology – Our VIPER® platform detects ACTIVE infections with accuracy and speed.

VIPER® Technology

Other VIPER® Applications

Chronic PJI
RenoTact®
Rapid Detection of PD Peritonitis
Allergies
SynoTact®
Rapid Detection of Periprosthetic Joint Infections
Syphilis
SpiroTact®
Rapid Detection of Syphilis Infection
Tuberculosis
EnzoTact®
Preventing Milk Spoilage with Rapid Protease Detection

MycoTact® is currently for research use only and is not for use in diagnostic procedures; the performance characteristics of this product have yet to be established